» Articles » PMID: 26940433

Synaptic Roles for Phosphomannomutase Type 2 in a New Drosophila Congenital Disorder of Glycosylation Disease Model

Overview
Journal Dis Model Mech
Specialty General Medicine
Date 2016 Mar 5
PMID 26940433
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation causes multisystemic defects that include severe neurological impairments, revealing a particularly critical requirement for tightly regulated glycosylation in the nervous system. The most common CDG, CDG-Ia (PMM2-CDG), arises from phosphomannomutase type 2 (PMM2) mutations. Here, we report the generation and characterization of the first Drosophila CDG-Ia model. CRISPR-generated pmm2-null Drosophila mutants display severely disrupted glycosylation and early lethality, whereas RNAi-targeted knockdown of neuronal PMM2 results in a strong shift in the abundance of pauci-mannose glycan, progressive incoordination and later lethality, closely paralleling human CDG-Ia symptoms of shortened lifespan, movement impairments and defective neural development. Analyses of the well-characterized Drosophila neuromuscular junction (NMJ) reveal synaptic glycosylation loss accompanied by defects in both structural architecture and functional neurotransmission. NMJ synaptogenesis is driven by intercellular signals that traverse an extracellular synaptomatrix and are co-regulated by glycosylation and matrix metalloproteinases (MMPs). Specifically, trans-synaptic signaling by the Wnt protein Wingless (Wg) depends on the heparan sulfate proteoglycan (HSPG) co-receptor Dally-like protein (Dlp), which is regulated by synaptic MMP activity. Loss of synaptic MMP2, Wg ligand, Dlp co-receptor and downstream trans-synaptic signaling occurs with PMM2 knockdown. Taken together, this Drosophila CDG disease model provides a new avenue for the dissection of cellular and molecular mechanisms underlying neurological impairments and is a means by which to discover and test novel therapeutic treatment strategies.

Citing Articles

Comprehensive insights into the impact of bacterial indole-3-acetic acid on sensory preferences in Drosophila melanogaster.

Aziz R, Ramesh P, Suchithra K, Stothard P, Narayana V, Raghu S Sci Rep. 2024; 14(1):8311.

PMID: 38594449 PMC: 11003987. DOI: 10.1038/s41598-024-58829-7.


A phosphate-sensing organelle regulates phosphate and tissue homeostasis.

Xu C, Xu J, Tang H, Ericsson M, Weng J, DiRusso J Nature. 2023; 617(7962):798-806.

PMID: 37138087 PMC: 10443203. DOI: 10.1038/s41586-023-06039-y.


FMRP activity and control of Csw/SHP2 translation regulate MAPK-dependent synaptic transmission.

Leahy S, Song C, Vita D, Broadie K PLoS Biol. 2023; 21(1):e3001969.

PMID: 36701299 PMC: 9879533. DOI: 10.1371/journal.pbio.3001969.


Protease-dependent defects in N-cadherin processing drive PMM2-CDG pathogenesis.

Klaver E, Dukes-Rimsky L, Kumar B, Xia Z, Dang T, Lehrman M JCI Insight. 2021; 6(24).

PMID: 34784297 PMC: 8783681. DOI: 10.1172/jci.insight.153474.


Identification of GOLPH3 Partners in Unveils Potential Novel Roles in Tumorigenesis and Neural Disorders.

Sechi S, Karimpour-Ghahnavieh A, Frappaolo A, Di Francesco L, Piergentili R, Schinina E Cells. 2021; 10(9).

PMID: 34571985 PMC: 8468827. DOI: 10.3390/cells10092336.


References
1.
Min K, Tatar M . Restriction of amino acids extends lifespan in Drosophila melanogaster. Mech Ageing Dev. 2006; 127(7):643-6. DOI: 10.1016/j.mad.2006.02.005. View

2.
van Dijk W, Koeleman C, van het Hof B, Poland D, Jakobs C, Jaeken J . Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). FEBS Lett. 2001; 494(3):232-5. DOI: 10.1016/s0014-5793(01)02349-3. View

3.
Llano E, Pendas A, Aza-Blanc P, Kornberg T, Lopez-Otin C . Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development. J Biol Chem. 2000; 275(46):35978-85. DOI: 10.1074/jbc.M006045200. View

4.
Glasheen B, Kabra A, Page-McCaw A . Distinct functions for the catalytic and hemopexin domains of a Drosophila matrix metalloproteinase. Proc Natl Acad Sci U S A. 2009; 106(8):2659-64. PMC: 2636737. DOI: 10.1073/pnas.0804171106. View

5.
Freeze H, A Eklund E, Ng B, Patterson M . Neurological aspects of human glycosylation disorders. Annu Rev Neurosci. 2015; 38:105-25. PMC: 4809143. DOI: 10.1146/annurev-neuro-071714-034019. View